---
figid: PMC3315368__nihms307798f4
figtitle: Gene Array Data from CWR22RV1 xenografts treated with PD325901 for three
  weeks
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3315368
filename: nihms307798f4.jpg
figlink: /pmc/articles/PMC3315368/figure/F4/
number: F4
caption: Pathway Analysis of Gene Array Data from CWR22RV1 xenografts treated with
  PD325901 for three weeks. Three tumors per treatment group were analyzed by Affymetrix
  HgU133_Plus 2 gene chips. Shown is a schematic of the canonical MAPK pathway as
  described by Pathway Express. A black box with white letters denotes upregulated
  gene products.
papertitle: Compensatory pathways induced by MEK inhibition are effective drug targets
  for combination therapy against castration resistant prostate cancer.
reftext: Daniel Gioeli, et al. Mol Cancer Ther. ;10(9):1581-1590.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8355437
figid_alias: PMC3315368__F4
figtype: Figure
redirect_from: /figures/PMC3315368__F4
ndex: 2b2391a2-df15-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3315368__nihms307798f4.html
  '@type': Dataset
  description: Pathway Analysis of Gene Array Data from CWR22RV1 xenografts treated
    with PD325901 for three weeks. Three tumors per treatment group were analyzed
    by Affymetrix HgU133_Plus 2 gene chips. Shown is a schematic of the canonical
    MAPK pathway as described by Pathway Express. A black box with white letters denotes
    upregulated gene products.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CACNA1A
  - CACNA1B
  - CACNA1C
  - CACNA1D
  - CACNA1E
  - CACNA1F
  - CACNA1G
  - CACNA1H
  - CACNA1I
  - CACNA1S
  - CACNA2D1
  - CACNA2D2
  - CACNA2D3
  - CACNA2D4
  - CACNB1
  - CACNB2
  - CACNB3
  - CACNB4
  - CACNG1
  - CACNG2
  - CACNG3
  - CACNG4
  - CACNG5
  - CACNG6
  - CACNG7
  - CACNG8
  - MAPT
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - RAPGEF2
  - STMN1
  - RASGRF1
  - RASGRF2
  - RASGRP1
  - RASGRP2
  - RASGRP3
  - RASGRP4
  - NGF
  - PLA2G4A
  - KAT5
  - NTRK2
  - NTRK1
  - BDNF
  - BDNF-AS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - NTF3
  - SORT1
  - NTF4
  - MKNK1
  - MKNK2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - RPS6KA3
  - RALB
  - EGF
  - LAMTOR3
  - PITRM1
  - EGFR
  - MAP2K2
  - ELK1
  - KCNH4
  - KCNH8
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAP2K1
  - PPP6R3
  - PDGFRB
  - PDGFRA
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - MYC
  - MOS
  - MOCOS
  - SLC25A3
  - REG1A
  - PTPRU
  - NF1
  - RASA2
  - RASA1
  - PPP3CA
  - PPP3CB
  - PPP3CC
  - Phosphatidylinositol
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
